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Stadler,3 Suzanne Roark,3 Elizabeth Hogg,3 and
Lawrence A. Frohman'
The purposeofthisstudy wastodeterminewhether a4-weekconsumptionof1.5L perdayofdrinkingwatercontain-
ing monochloramine at a concentration of2 ppm (ppm = mg/L) or 15 ppm under controlled conditions would alter
parametersoflipid orthyroidmetabolisminhealthy men.Forty-eight mencompleted an8-weekprotocolduringwhich
diet (600 mgcholesterol perday, 40% calories asfat) andotherfactorsknowntoaffectlipidmetabolism werecontrolled.
During the first4 weeksofthe protocol, an subjects consumed distilled water. Duringthesecond4 weeks, one-third of
thesubjects wereassigned randomly todrink 1.5 L perdayofwatercontaining2 ppm ofmonochloramine, todrink 1.5
L perday ofwatercontaining 15 ppmmonochloramine, ortocontinue driking distifledwater. Fourbloodsamples were
collected from eachsubjectattheendofeach4-weekstudy period. Subjectsdrinkingmonochloramineat aconcentra-
tion of 2 ppm showed no significant changes in total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol,
apolipoproteinsAl, A2, orB whencomparedtothedistilledwater group. Parametersofthyroidfunctionalso were un-
changedby exposuretomonodoraineatthisconcentration. However,subjectsdrinkingmonochloranmineat aconcen-
trationof15 ppmecperienced anince inthe evel ofapolipoproteinB. Otherparanetersof ipidandthyroidmetabolism
did notchange. We conclude that consumption ofdrinking watercontaining 2 ppm ofmonochloramine does not alter
parametersoflipidandthyroidmetabolisminhealthy men. Consumptionofwatercontaining 15 ppmmonochloramine
may be associated with increased levelsofplasma apolipoprotein B.
Introduction
Exposure ofhumans to chlorinated drinking water disinfec-
tants isalmostuniversal intheUnitedStates (1). Chlorineisthe
disinfectant used by the majority ofpublic water systems that
disinfecttheirwater, butchloramine isalsousedinanumberof
areas atpresent. Moreover, ithasbeensuggested ihatchloramine
wouldbethepreferredagentto usewithnewerdisinfectantssuch
as ozone inordertoachieve aneffective residualofdisinfectant
in water distribution systems.
Revisandcolleagues havestudiedtheeffectofdrinking water
chlorineandmonochloramine onlipidandthyroidmetabolism
in white Cameau pigeons (2). Pigeons consuming a high-fat,
high-cholesterol, low-calciumdietexperienced asignificantin-
crease in serum cholesterol and a decrease in serum thyroxine
when given chlorinated water to drink. Similar findings were
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seenwithmonochloramine at2ppm(ppm = mg/L)and 15ppm.
Theseeffectswereobservedatconcentrationsofdrinkingwater
disinfectants near the rangetypically consumed byhumans.
Investigationsoftheeffectsofchlorineandmonochloramine
onhumanlipidandthyroidmetabolismarelimited. Lubbersand
colleagues exposed healthy human volunteers to low and high
concentrations of chlorine, monochloramine, and other
chlorinateddisinfectants forbriefintervals andobservednoef-
fectontotalcholesterollevels(3). Moreprolongedexposureto
5ppmchlorineandmonochloraminealsohadnoapparenteffect.
However, dietandtheintakeofotherliquidspossiblycontaining
chlorinateddisinfectantswereuncontrolled, sothesestudiesdo
not effectively exclude the possibility that chlorine or mono-
chloramine affects human lipidmetabolism.
Wonesandcolleagueshaveconductedtwostudiesofdrinking
waterchlorineandhumanlipidmetabolism. Thefirstwasanun-
controlled 15-week dose-response trial of drinking water
chlorine(0,2, 5, 10ppm)in 19healthymeninwhichaclinical-
ly smallincrease(3%)intotalcholesterollevelsatchlorinecon-
centrationsof5 ppmand 10ppmwasobserved(4). However, no
controlgroupwasstudied, anditispossiblethattheobservedin-
creasewasduetotheprotocoldietorotherfactorsandnottothe
chlorine.3INESETAL.
The second study was acontrolled 8-weekstudy involving 30
menand 30women (5). All subjectsdrankdistilledwaterforthe
first 4 weeks ofthe protocol. Halfwere randomized to receive
chlorinateddrinking water(20ppm) forthe next4weeks, while
the other halfcontinued to drink distilled water. No effect on
parametersoflipidorthyroid metabolism wasobservedfromthis
short-term exposure to chlorine.
Zeighami and colleagues have reported an epidemiological
study of40 small Wisconsin communities, 20 ofwhich chlor-
inatedtheirwatersupplyand20ofwhichdidnotchlorinatetheir
water supply (6). Older women (40-60 years) living in com-
munities with chlorinated supplies appeared to have slightly
higher total cholesterol levels (about5%) thanwomenliving in
communities with unchlorinated supplies, thoughtherewas no
significantdifference found formen. Nosimilarepidemiological
data are available for monochloramine.
Thus, studies in humans are insufficient eithertoconfirm or
to exclude an effect of monochloramine in drinking water on
human lipid or thyroid metabolism. The purpose ofthis study
was todetermine ifdrinking watercontaining monochloramine
atconcentrations of2 ppmor 15 ppm wouldaffectparametersof
lipid or thyroid metabolism in healthy men unselected for
baseline total cholesterol levels.
Methods
This study was a randomized, controlled, parallel trial of8
weeks' duration. Neitherthe subjects northe investigators were
blinded as to who received monochloramine and who did not.
The study protocol is illustrated inFigure 1. Theprotocol con-
sisted ofa4-weekdietary stabilizationperiodduring which all
subjects drank distilled water buffered with sodium mono-
phosphate to a pH of8.5. The purposes ofthe baseline period
were to achieve stabilization on a high-fat, high-cholesterol
dietandtoallowtheeffectsofpriorexposuretochlorinated water
todissipate. Thebaselineperiod was followedby a4-weektreat-
mentperiodduringwhichone-thirdofthesubjectswereassigned
randomly to continue consuming buffered distilled water
(distilled group), one-third wereassigned toconsume 1.5 Lper
day ofdrinking water containing 2 ppm monochloramine buf-
feredwithsodiummonophosphatetoapHof8.5 (2ppmgroup),
andone-third were assigned to consume 1.5 L perday ofwater
containing 15ppmmonochloraminebufferedtopH8.5 (15 ppm
group). The alkaline pH was used to mimic natural drinking
waters, most of which are alkaline, and to ensure that the
monochloramine did not become dichloramine. The trial was
conducted inthe General Clinical Research Center (GCRC) at
theUniversityofCincinnati Hospitalandwasapprovedby itsIn-
stitutional Review Board. All subjects gave written informed
consent to participate.
Inclusioncriteriaforthestudy includedhealthymenbetween
theagesof 18and65 years, nomedications, and no concurrent
illnesses. Screening total cholesterol measurements before
enrollment into the study wereperformed forall potential sub-
jects. Menwhomettheinclusioncriteriawereselected forstudy
in such a way that one-fourth had screening total cholesterol
measurements in each quartile for their age according to the
Lipid Research Clinic's Prevalence Study (7). Subjects were
stratified by screening total cholesterol quartile before ran-
domization into groups so that each group included equal
numbers ofhigh-, middle-, and low-cholesterol subjects.
The study used one monochloramine concentration (2 ppm)
in the range typically found in public water systems and one
monochloramineconcentration (15 ppm) somewhathigherthan
thatusually foundinpublic watersystems. Theseconcentrations
were the same as those at which Revis found effects in pigeons
(2). Drinking water for each subject was preparedby standard
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procedures. Water was distilled and filtered through activated
charcoal to remove any trace organic impurities. Before laun-
ching the study, samples ofthe resulting purifiedwaterwere sub-
mittedtotheEnvironmental Protection Agency (EPA) HealthEf-
fects Research Laboratory in Cincinnati and werejudged to be
free oftrace organic impurities.
A sodium monophosphate buffer solution was prepared by
dissolving 60gNaH2PO4in500mLdistilledwaterandadjusting
the pH to 8.5 with 2N NaOH. This solution wasdilutedto 1.0L
with distilled water. A concentrated monochloramine solution
was prepared as follows: 1 mL of a concentrated ammonium
hydroxide (28%) solution and 160 mL of the buffer solution
described above were mixed in 3400mLdistilled-water. Then,
13 mLofaconcentrated chlorine solution (chlorinegasbubbled
into a 1.0 L solution of240g/L NaOHuntil thepHfalls to 12.0)
were added to 500 mL distilled water. The pH ofthe chlorine
solution andthe pH ofthebuffered ammoniumhydroxide solu-
tions were adjusted as necessary to pH 8.5 with HCI. The
chlorine solution was thenadded immediately totheammonium
hydroxide solution with constant stirring. The concentration of
the final solution was 100-120 mg/L (as chlorine). Each day,
GCRC dietary staffmixed analiquot ofthe concentrated mono-
chloramine solution with distilled water to prepare that day's
drinking water for each subject. The final pH andchlorine con-
centration ofone subject's drinking water wascheckedeachday
toassure that subjects actually received theappropriateconcen-
tration ofmonochloramine. Each subject's daily drinking water
was prepared and stored in a well-marked thermos.
Subjects were also provided with athermos ofdistilled water
free ofmonochloramine and buffer, which they could drink at
theiroption inaddition tothe 1.5 Lofstudy water which they had
to drink. Consumption of mandatory and optional water was
monitored bydaily checksofsubjects' thermoses. Twenty-four-
hour fluid intakes were recorded daily.
The study diet was designed individually to satisfy the food
preferences ofeach subject and to be isocaloric. Each subject's
dietplan wasadjusted as necessary byaGCRC dietitianto main-
tain the subject at his orheradmission weight. Thedietconsisted
of20% protein, 40% carbohydrate, and 40% fat. It contained
600mg ofcholesterol/day and apolyunsaturated tosaturated fat
ratio of0.4. Dietary calcium was restricted to 80% ofthe mini-
mum daily requirement for American adults.
The characteristics ofthe study diets were designed to mimic
Revis' study in pigeons (2). Therefore the study diets were
relatively high in total fat, saturated fat, and cholesterol. Despite
the high fat and cholesterol content, such diets are not unusual
formany Americans. Only overthe lastdecade haveAmericans
consumed less fat and cholesterol on average (8). The calcium
restriction also reflects nutritional patterns in thiscountry since
many people, especially women and older Americans, consume
a diet containing 80% orless ofthe recommended daily allow-
ance ofcalcium (9). Study diets wereformulated to avoid foods
that contain chlorine (i.e., bleached flour). Thus, the study diets
were designed to maximize the potential for observing a small
effect of monochloramine on lipid and thyroid metabolism,
minimize the influence ofextraneous dietary confounders, and
preserve generalizability.
All food was prepared in the GCRC kitchen. Two daily meal
plans were used foreach subject so thateach personatethe same
mealseveryotherday for56days. Subjectswererequiredtoeat
atleasttwomealsandtodrinkthe 1.5Lofstudydrinking water
each day in the GCRC under observation. A third meal and a
snack were packed for those subjects who wanted to consume
them athomeoratwork. Subjects were instructednottoeator
drink anything that had notbeen provided forthem.
Otherlifestylefactorswhichmightaffectlipidorthyroidlevels
werecontrolledaswellaspossible. Subjectswerenotpermitted
to drink alcohol. Ifthey smoked cigarettes, they were asked to
keep their smoking constant throughout the study. They kept
diariesofexerciseactivities andwerealsoaskedtokeeptheirex-
ercise habits constant. Subjects were required to refrain from
swimming during the study toavoid exposure tochlorine from
pool water.
Weight, blood pressure, pulse rate, and temperature were
measured eachmorning inafasted stateby aGCRCstaffnurse.
Blood was drawn at entry to the study and weekly for total
cholesterol, triglycerides, andHDLcholesterol (HDL-C). These
testswereobtaineddailyfor4consecutivedaysattheendofthe
baseline and treatment periods (week 4, week 8). Blood was
drawn alsoon4consecutive days attheendofthebaseline and
treatment periods forapolipoproteins Al, A2 andB, thyroxine
(T4), triiodothyronine (T3), T3 resin uptake, and thyroid-
stimulating hormone (TSH). Ondays0, 28, and56, safety tests
(serumelectrolytes, bloodureanitrogenandcreatinine, glucose,
liver transaminases and alkaline phosphatase, calcium and
phosphorous, urinalysis, whiteandredbloodcellcounts, reticu-
locytecount, andmethemoglobin) weredrawn. Glucose6-phos-
phatedehydrogenase (G6PD) wasmeasured uponentry intothe
study todetectindividualswhomightbesusceptibletohemolytic
anemiaduetotheoxidizingeffectsofmonochloramine. Noneof
the subjects was G6PD deficient.
All blood samples were drawn from the antecubital veins of
supine subjects. Blood forlipid, lipoprotein, andapolipoprotein
analyses werecollected insodium/potassium ethylenediamino-
tetracetate (EDTA, 1 mg/mL) anticoagulated tubes, and the
plasma was rapidly separated by centrifugation and frozen at
-20°C. Allsamplesfromindividualsubjects wereanalyzedas
abatch attheendoftheprotocol. Totalcholesterol,triglycerides,
and HDL cholesterol were measured by microenzymatic pro-
cedures, standardized, and monitored through the Center for
DiseaseControl's LipidStandardizationProgram(10). HDLwas
isolated using the modified heparin-manganese chloride pro-
cedure (11). Interference intheenzymaticprocedure waselimi-
nated by the addition of 8 mEq/L ofEDTA to the cholesterol
reagent (12). Apolipoproteins (apo) Al and Bwerequantitated
by electroimmunoassay (13) and apo A2by enzyme-linked im-
munoabsorbant assay (14). LDL cholesterol (LDL-C) was
calculatedastotalcholesterolminus HDL-Cminustriglycerides
divided by 5. Theothertests listedabove wereperformedbythe
clinical laboratories oftheUniversityofCincinnati Hospital us-
ing standard procedures.
Results ofthe lipidandthyroidfunction tests wereanalyzed as
follows. Foreach subject, themeanofthefourconsecutivedai-
ly measurements duringweek4was considered the "baseline"
value and themeanofthefourdaily measurementsduring week
8 the "treatment" value. The "change" value foreachperson was
defined as the treatment value minus the baseline value. The
meansofthechangevalues forthethreegroups werecompared
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using aone-way analysisofvariance. Pairwiset-tests wereused
tocompareeachchloraminegroupwiththedistilledgroupifthe
ANOVA suggestedthatasignificantdifferenceofthemeans ex-
isted. A comparison ofthe weekly values oftotal cholesterol,
triglycerides, and HDL-C was made also using a repeated
measures analysis ofvariance. Allp-values are two-tailed.
Results
Forty-eight menenteredthestudyprotocolandallcompleted
it. DemographicdataforthesubjectsbygroupareshowninTable
1. Therewerenostatistically significantdifferencesbetweenthe
groups for age, weight, orentry totalcholesterol.
Baseline, treatment, andchangelipidandthyroidfunctiontest
results forthesubjects inthemonochloramineanddistilled water
groupsareshowninTable2. Thethyroiddataforonesubjectin
the 15 ppm monochloramine group were excluded before
analysisbecausehewasfoundtobechemicallyhypothyroid(low
T4, high TSH) over the duration ofthe study. Inclusion ofhis
thyroid results did notchange the results ofthe analysis, but it
would havemadethebaselineandtreatmentlevelsofT4appear
much lower and the mean level ofTSH much higher than the
other two groups.
Therewerenodifferencesbetweenthemonochloramineand
distilled water groups for changes in any ofthe parameters of
Table 1. Demographic data ofmalesubjects.
Group
Distilled Chloramine, Chloramine,
water 2 ppm 15 ppm
Numberofsubjects 16 16 16
Age, years
Mean ± SD 26.9 ± 7.2 27.8 ± 6.8 27.2 ± 6.0
Range 21-50 23-47 21-39
Weight, kg
Mean ± SD 77.2 ± 10.7 72.5 ± 9.6 74.6 ± 6.4
Range 66-107 60-98 61-83
Total cholesterol at entry,
mg/dL
Mean ± SD 171.4 ± 29.6 172.6 ± 34.9 173.1 ± 30.4
Range 105-234 107-262 137-244
Race
Caucasian 14 14 15
Black 1 2 1
Other I 0 0
Previous sourceofdrinking
water
Tap 13 14 13
Bottled 3 2 3
Well 0 0 0
Table2. Effectsofmonochloramnine onUpidandthyroid metabolism inmen.
Parameter
Total chloesterol,
mg/dL
HDLcholesterol,
mg/dL
LDL cholesterol,
mg/dL
Triglycerides, mg/dL
LDL:HDL ratio
Apolipoprotein A,,
mg/dL
Apolipoprotein A2,
mg/dL
Apolipoprotein B,
mg/dL
T4, tg/dL
T3, ng/dL
T3 Resin uptake, %
Thyroid-stimulating
hormone,U/mL
No. ofsubjects
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
15
16
16
15
16
16
15
16
16
15
Group
Distilled
2 ppm Monochlor
15ppm Monochlor
Distilled
2 ppm Monochlor
15ppm Monochlor
Distilled
2 ppm Monochlor
15ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
Distilled
2 ppm Monochlor
15ppm Monochlor
Distilled
2 ppm Monochlor
15ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
Distilled
2 ppm Monochlor
15 ppm Monochlor
p-Valuec
0.23
0.08
0.52
0.07
0.38
0.30
Baseline
175.7 ± 6.23
182.7 ± 8.75
186.8 ± 9.91
46.4 ± 2.47
47.6 ± 2.57
46.8 ± 2.00
113.6 ± 5.81
119.4 ± 7.78
124.4 ± 9.79
81.3 ± 7.55
78.6 ± 11.94
79.0 ± 15.67
2.57 ± 0.20
2.58 0.20
2.79 0.30
126.7 ± 2.97
127.8 ± 3.76
124.5 ± 2.74
40.1 ± 2.73
37.4 ± 1.16
38.2 ± 2.64
99.9 ± 7.17
102.8 ± 7.50
104.2 ± 7.60
6.89 0.21
6.90± 0.12
7.04 0.23
127.0 ± 4.99
123.0 ± 4.37
120.6 ± 3.95
98.4 ± 3.28
99.1 ± 1.83
97.4 ± 2.16
2.60± 0.21
2.69 0.21
2.75 0.25
Treatment
179.7 ± 5.15
182.2 ± 9.54
193.8 ± 10.11
48.4 ± 2.71
47.4 ± 2.36
47.2 ± 1.99
116.6 ± 5.24
119.9 ± 8.38
128.8 ± 10.62
74.0 ± 6.13
74.8 ± 11.04
85.0 ± 17.75
2.54 0.19
2.59± 0.21
2.87± 0.33
127.7 ± 2.82
125.5 ± 3.63
126.0 ± 2.80
41.0 ± 2.55
38.5 ± 1.51
39.1 ± 2.65
98.2 ± 5.35
101.2 ± 7.28
116.4 ± 9.45
6.80± 0.23
6.71 0.18
7.02 0.22
125.5 ± 4.60
121.6 ± 3.86
119.1 ± 3.96
98.3 ± 3.22
98.8 ± 1.90
96.8 ± 2.13
2.61 0.21
2.60± 0.18
2.75± 0.26
Change"
+4.0
-0.5
+7.0
+2.0
-0.2
+0.4
+3.0
+0.5
+4.4
-7.3
-3.8
+6.0
-0.03
+0.01
+0.08
+1.0
-2.3
+1.5
+0.9
+1.1
+0.9
-1.7
-1.6
+ 12.2
-0.09
-0.09
-0.02
-1.5
-1.4
-0.5
-0.1
-0.3
-0.6
+0.01
-0.09
+0.00
0.95
0.02
0.28
0.98
aMean ± SEM for each parameter.
'Change = treatment (week8)
- baseline (week 4).
cThep-value shown is the probability that thechange values forthe three groups are the sane (one-way analysis ofvariance).
0.92
0.68
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lipid orthyroid metabolism exceptapolipoprotein B. A modest
increase inapolipoprotein Bconcentration wasobserved inthe
groupthatdrank watercontaining 15 ppmmonochloramine. The
individual apolipoprotein data were examined for each ofthe
subjects in the 15 ppm group to see whether this change in the
mean value was due to alarge change in a few subjects or more
modestchanges in many subjects. Elevenof16 increased while
five of 16 decreased. Six subjects increased more than 10%,
while only one subject decreased by more than 10%. Thus, the
observed change in meanapolipoprotein B levels was notdueto
a large change in one or a few individuals.
Apolipoprotein B is found in LDL and VLDL (very low-
density lipoprotein). In the fasting state, most of the plasma
triglycerides are carriedby VLDL; thus, triglyceride concentra-
tions are a good surrogate forVLDLconcentrations (as long as
triglycerides are less than400 mg/dL). There was atrend toward
increased triglyceride concentrations (and presumed increased
VLDL) in the 15 ppm group but no change in LDL. This might
suggest that the increase in apolipoprotein B was due to an in-
crease in VLDL. However, there was only aborderline correla-
tion between changes in triglycerides and changes inapolipopro-
tein B in the 15 ppm group(Pearson r = 0.45;p = 0.08), which
depended almostentirely onthe results from one subject. Ifthe
data for this subject were excluded, no correlation existed. In
contrast, even though mean LDL did not increase, there was a
correlation (Pearson r = 0.56, p = 0.02) between individual
changes in apolipoprotein Band LDLcholesterol concentrations
forthe men exposed to 15ppm monochloramine, which did not
depend on the results ofany one subject.
The chloramine solutions were well tolerated bythe subjects.
No new, significant abnormality in any safety testwas noted in
any subject. Two subjects in the distilled water group, two sub-
jects in the 2 ppm chloramine group, and three subjects in the 15
ppm chloramine group experienced intermittent diarrhea (2-10
episodes) during the study. Two subjects in the 15 ppm group
developed a sore throat with exposure to monochloramine, and
two experienced intermittent mild headaches. Theseeffects were
not noted in the other groups. The doseofmonochloramine had
to be reducedto7.5 ppmforatotal of6days foroneofthe 15 ppm
subjects with a sore throat because he believed the disinfectant
was the cause ofhis symptoms.
Discussion
The short-term (4 weeks) consumption ofdrinking water con-
taining 2 ppm monochloramine did not affect any parameters of
lipid or thyroid metabolism in the healthy men studied. The
short-term consumption of drinking water containing 15 ppm
monochloramine wasassociated withanincrease inthe level of
plasmaapolipoprotein B, butthere were no significant changes
in other parameters oflipid and thyroid function.
These results with 2 ppm monochloramine areconsistent with
the negative results we have found previously with short-term ex-
posure of healthy men and women to drinking water chlorine
with aconcentration of20ppm (5). The increase inthe level of
apolipoprotein Bobserved in men drinking 15 ppmmonochlor-
amine contrasts with our results with drinking water chlorine,
where we observed no changes in apolipoprotein B. The other
studiesoftheIipideffectsofchlorinateddisinfectants cited inthe
Introductiondidnotincludeapolipoprotein measurements (2,3,6).
Apolipoprotein Bis aprotein foundonly in LDL and VLDL
lipoproteins (15). Thereisexactlyoneapolipoprotein Bmolecule
ineach LDLparticle. Thenumberofapolipoprotein Bproteins
associated with each VLDLparticle is unknown, though itpro-
bably is one also since VLDL particles are converted to LDL
particles in the blood as triglycerides are removed from them,
and noaddition orremoval ofapolipoprotein B isthought tooc-
cur during this process. If the composition of the LDL and
VLDLparticles remainedunchanged, anincrease inapolipopro-
tein Bwouldbeassociatedwith an increase in LDLcholesterol
concentration, anincreaseintriglycerides (sincealmostallofthe
triglycerides inthefastingstateareinVLDLparticles), oranin-
crease inboth. NochangeincalculatedLDLcholesterol concen-
tration was apparent in the 15 ppm group. There was a trend
toward increased triglycerides inthisgroup, though themagni-
tudeofthis apparent change was small, the trenddid not reach
statistical significance, and the correlation was completely
dependentontheresults fromonesubject. Therewas, however,
a good correlation between changes in apolipoprotein B and
changes in LDL cholesterol. In other words, subjects who ex-
perienced an increase in apolipoprotein B levels also tended to
experience an increase inLDLcholesterol levelseventhoughthe
group meansfor LDLcholesterol didnotreflectthesechanges.
One explanation for an observed change in apolipoprotein B
without a statistically significant change in LDL cholesterol is
that apolipoprotein B levels maybeamore sensitiveandaccurate
marker for LDL levels and that the LDL cholesterol concentra-
tions werenotsensitive enough todemonstrate achange. Another
explanationisthatthecompositionofLDLlipoproteins canvary.
If the composition of LDL particles changed such that less
cholesterol waspresentineachparticle, thenitwouldbepossible
tohaveanincreaseinthenumberofparticleswithoutanassociated
equivalent increase in plasma LDLcholesterol concentration.
Becausethe study protocol involved 11 plannedcomparisons
of parameters among the groups, the finding of an effect on
apolipoprotein B levels could represent a chance result rather
than a real change. Thus, additional studies toconfirmthisfind-
ing are required.
Theprincipal limitations ofthis study includea) therelatively
brief baseline and treatment periods and b) consumption by
almost all subjectsofchlorinated drinking water from local water
supplies before entry into the protocol. The duration of the
4-weekbaseline period may not havebeen sufficient to achieve
adequate washout ofthe effects ofpreviously ingested chlorine.
Alternatively, the 4-week treatment period may have been too
brief to see an effect from exposure to monochloramine. The
length ofthebaseline and study periods was chosenbased on the
clinical observation thatmostfactorsthataffectbloodcholesterol
levels, including diet, do so within a time span of4 weeks (16).
Also, practical considerations involved with studying normal
human subjectslimitedthemaximumpossiblelengthofexposure.
Insummary, this randomized, controlled trial failed to show
any effect ofdrinking water monochloramine ataconcentration
of2 ppmonparameters oflipid orthyroid metabolism in healthy
men. Drinking water monochloramine at a concentration of 15
ppm was associated with an increase inapolipoprotein B levels.
Given the limitations of this study, these results argue against
changes in disinfection practices involving low levels (2 ppm or
less) of monochloramine and argue for further studies of the
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possible relationship ofhigh-level exposureto monochloramine
and apolipoprotein B metabolism.
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